Global Generalized Anxiety Disorder Treatment Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Antidepressant, Buspirone, and Benzodiazepines), By Therapies (Interpersonal Therapy, Behavioural Therapy, Cognitive Behaviour Therapy, and Mindfulness Based Cognitive Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
Premium Report Details
Base Year:
2024
Tables & Figures:
90
Pages:
240
Countries covered:
18
Companies covered::
20
Forecast CAGR:
CAGR Of 8.82%
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies